Uncontrolled asthma on GINA step 4-5 treatment increases healthcare utilization – report from the population-based OLIN-studies

C. Stridsman (Luleå, Sweden), H. Backman (Luleå, Sweden), L. Hedman (Luleå, Sweden), E. Rönmark (Luleå, Sweden)

Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses
Session: Nursing care across the spectrum of respiratory illnesses
Session type: Thematic Poster
Number: 1263
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Stridsman (Luleå, Sweden), H. Backman (Luleå, Sweden), L. Hedman (Luleå, Sweden), E. Rönmark (Luleå, Sweden). Uncontrolled asthma on GINA step 4-5 treatment increases healthcare utilization – report from the population-based OLIN-studies. 1263

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


Perception of asthma control by patients: results of a survey in 5 European countries
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007




Characteristics of the uncontrolled asthmatic patients on GINA step 4 treatment in Korea
Source: Annual Congress 2012 - Epidemiology of asthma
Year: 2012

The impact of the addition of omalizumab on the utilization of healthcare resources by severe persistent asthma patients
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Is asthma treatment compliance improved over the last ten years? The results of the European community respiratory health survey (ECRHS)-II
Source: Annual Congress 2004 - Asthma and allergy overtime: risks and management
Year: 2004


REG study: Real-life, longitudinal ICS adherence patterns in a UK asthma population
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Improvement in asthma control and reduction in medical resource use following treatment with montelukast (PRAACTICAL Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

Effectiveness of montelukast on asthma control in infants: A claims data study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Change of COPD maintenance medication over two years in a large real life cohort: The DACCORD study
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Changes in prescriped inhaled COPD medication during a 3 year period in Denmark. A registry study
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013


Cost and effectiveness of 2 years integrated care intervention in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006


The impact of incentives on the implementation of asthma or diabetes self-management: A systematic review
Source: International Congress 2016 – Asthma management in primary care
Year: 2016


Evaluation of a diagnostic–therapeutic pathway on GINA guidelines between specialist and primary care physicians. Study and result at 1 year in children with asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Has asthma control improved since AIRE? Results of a survey in 5 European countries
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007




Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015


What clinical features underlying GINA step 1-4 drive the level of treatment in patients with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 57s
Year: 2001